Engineered iPS Derived T-Cells for Solid & Hematological Tumours
Time: 12:30 pm
Details:
- Engineered iPS derived cell therapies can be designed to overcome multiple mechanisms of treatment failure and relapse
- PSC derived therapies provide a homogenous and uniform source of off-the-shelf cell therapy products
